No photo of Chafic Y. Karam
Contact Expert

View Scopus Profile

Chafic Y. Karam

    • 208 Citations
    • 9 h-Index
    20072018
    If you made any changes in Pure these will be visible here soon.

    Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

    Amyotrophic Lateral Sclerosis Medicine & Life Sciences
    Intravenous Immunoglobulins Medicine & Life Sciences
    Polyneuropathies Medicine & Life Sciences
    Differential Diagnosis Medicine & Life Sciences
    Vitamin D Medicine & Life Sciences
    Muscle Weakness Medicine & Life Sciences
    Charcot-Marie-Tooth Disease Medicine & Life Sciences
    Paresthesia Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 2014 2017

    A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to evaluate the safety and efficacy of Eculizumab in subjects with Refractory Generalized Myasthenia Gravis (gMG)

    Howard, J. F. & Karam, C. Y.

    Industry Sponsor

    2/28/14 → 2/27/17

    Project: Research project

    Myasthenia Gravis
    Multicenter Studies
    Placebos
    Safety
    eculizumab

    Research Output 2007 2018

    Swallowing and Secretion Management in Neuromuscular Disease

    Britton, D., Karam, C. & Schindler, J. S., Jun 1 2018, In : Clinics in Chest Medicine. 39, 2, p. 449-457 9 p.

    Research output: Contribution to journal › Review article

    Neuromuscular Diseases
    Deglutition
    Deglutition Disorders
    Aspiration Pneumonia
    Social Isolation
    1 Citations

    ALSUntangled 38: L-serine

    The ALSUntangled Group, Jan 2 2017, In : Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18, 1-2, p. 148-151 4 p.

    Research output: Contribution to journal › Article

    ALSUntangled No. 36: Accilion

    The ALSUntangled Group, Jan 2 2017, In : Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18, 1-2, p. 142-147 6 p.

    Research output: Contribution to journal › Article

    1 Citations

    ALSUntangled No. 37: Inosine*

    The ALSUntangled Group, Apr 3 2017, In : Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18, 3-4, p. 309-312 4 p.

    Research output: Contribution to journal › Article

    Editors' Note

    Karam, C. & Griggs, R. C. Aug 1 2017 In : Neurology. 89, 5, 1 p.

    Research output: Contribution to journal › Editorial